Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Helixmith Co., Ltd.

Clinical trials sponsored by Helixmith Co., Ltd., explained in plain language.

Helixmith Co., Ltd. 084990 KOSDAQ

A South Korean biotech developing gene therapies for diabetic neuropathy and cancer.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 5 Completed 13 Terminated 1

Gene therapy for diabetic foot ulcers fails to reach finish line

Disease control Terminated

This study tested a gene therapy called VM202 to help heal chronic foot ulcers in people with diabetes and poor leg circulation. The treatment was given as injections into the calf muscle. The study was stopped early after enrolling only 44 participants, so results are limited.

Phase: PHASE3 • Sponsor: Helixmith Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 07:54 UTC